𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

✍ Scribed by Scott I. Bearman; Danny D. Shen; Mary S. Hinds; Harlan A. Hill; George B. McDonald

Book ID
114713192
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
681 KB
Volume
84
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Unrelated stem cell transplantation afte
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation : A prospective multicenter phase II study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
✍ Nicolaus KrΓΆger; Avichai Shimoni; Georgia Schilling; Rainer Schwerdtfeger; Marti πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 190 KB
Results of a phase I/II British Society
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation
✍ Z.Y. Lim; G. Cook; P.R. Johnson; Anne Parker; M. Zuckerman; D. Marks; H. Wiltshi πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 218 KB

This multi-centre randomized study assessed the bioavailability of ganciclovir in patients undergoing alemtuzumab-based reduced intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT) after oral administration of valganciclovir. Patients were randomized to 2 groups receiving eit